Zhe Yu

Practice Areas

Cross-border Investment/M&A, Private Equity & Investment Funds, Compliance & Investigation

Personal

Mr. Yu has nearly 20-year experience in cross-border investment and mergers and acquisitions, private equity investments, and other corporate matters. He serves clients in a variety of industries including manufacturing, consumer products, chemical, life sciences, manufacturing, natural resources, and agriculture. Mr. Yu represents multinational companies, private equity funds, and Chinese public companies in transactions in China and other jurisdictions with deal size ranging from multiple ten million US dollars to over one billion US dollars, and also represents private equity fund, marquee tech companies, and start-up companies in their equity and debt financing projects. Mr. Yu’s acumen business sense and constructive solutions often help clients to respond to challenges in complex transactions, helping clients to close deals.

Work Highlights

M&A

Represented Baring Private Equity Asia in the take-private acquisition of Ginko International which owns Hydron branded contact lens business.

Represented Koncentra Verkstads AB in its acquisition of the large-size piston business from Rheinmetall Group.

Represented Taiwanese Family company in its sale of a PRC leading medical device company to a Taiwan PE Firm.

Represented Xilinx in its acquisition of Deephi Technology, a start-up with industry-leading capabilities in machine learning, specializing in deep compression, pruning, and system-level optimization for neural networks.

Represented Imerys in its acquisition of Zhejiang Zr-Valley Sciences & Technology Co., Ltd., a leading producer of zirconium oxychloride and high purity zirconia products.

Represented Imerys in its acquisition from Lucion of a majority stake in Luxin Mount Tai, a leading supplier of abrasives in China.

Represented OSI Group in its buyout of a joint venture in Hebei province.

Represented Valmet in its acquisition of certain equity interests in a joint venture from a Chinese state-owned company.

Represented NXP in investment in a technology company via convertible loan and related IP licensing arrangements;

Represented NXP in investment in an auto-drive related technology company.

Represented as NXP’s China counsel on acquisition of Marvell’s WiFi and Bluetooth connectivity business.

Represented NXP in investment in a Pre-IPO tech company.

Acted as Onex Corporation’s APAC counsel in its US$2.35 billion acquisition of Eastman Kodak Company’s Health Care Group, renamed Carestream Health.

Represented Zhejiang Yinlun in acquisition of Thermal Dynamics LLC, a leading US thermal exchanger manufacturer.

Presented Zongyi Group: Investment in Kadmon, a biopharmaceutical company in the US.

Represented Intellcloud in its Pre-A equity financing.

Represented as Carestream’s APAC counsel of its sale of its dental digital business to funds managed by CD&R and CareCapital.

Acted as Carestream’s APAC counsel of the sale of its Healthcare IT business to Philips.

Jamesbury Valve Co., Ltd. To its joint venture partner, Shanghai Electronic International Economic & Trade Co., Ltd., a wholly owned subsidiary of Shanghai Electric (Group) Corporation.

Represented OSI Group in its sale of fresh cut business in Guangzhou to Golden State Food.

Represented OSi Group in its sale of business assets in Shanghai.

Represented OSI Group in its sale of equity interests in two joint ventures in Fujian to a Chinese public company.

Represented S.C. Johnson: acquisition of a super-majority stake in one of China’s leading manufacturers and distributors of pest control products, air fresheners, disinfectants, and household cleaners, and subsequent buyout of minority shareholders.

Represented miVIP in its sales of several ambulatory clinics to US buyers.

Represented as Imerys’ China counsel in its sale of the high-temperature solution business to Platinum Equity.

FDI, Joint Venture, and Strategic Alliance

Represented Align Technology in setup of its over one hundred million US dollar manufacturing facilities in Sichuan province.

Represented Polyplastics in its setup of multiple hundred million dollar facilities to manufacture engineering plastics.

Represented NXP in restructuring and recapitalization of a joint venture with Datang Telecom.

Represented Singaporean biotech Company in medical device licensing arrangement with a U.S. medical device company.

Represented a US sports equipment company in termination of the contract manufacturing arrangement with a company in Qingdao involving return of the inventory, intellectual properties and equipment.

Represented Indochino in exclusive strategic alliance arrangement including entering into a long-term supply and manufacturing agreement with China-headquartered global apparel manufacturer Dayang Group.

Represented OSI Group in food processing management and contract manufacturing arrangement in Guangzhou with a Golden States Foods entity.

Represented CETAC in the setup of a joint venture with Rockwell Collins to develop and manufacture the communication and navigation systems for COMAC C919 aircraft.

Represented CETAC in the recapitalization project to engage in R&D and manufacturing of avionics for aircrafts.

Represented Owens Corning in the strategic alliance with glass fiber producer Taishan Fiberglass (Sinoma) to produce specialty glass products sold under the brands Cem-FIL®, Anti–CRAK®, Slurry-FIL™.

Represented Owens Corning in the strategic alliance with Xingtai Jinniu Fiberglass Company to utilize Jinniu's existing glass fiber furnace capacity in China to provide a reliable supply of customized boron-free glass fiber reinforcements;.

Represented Owens Corning in the technology licensing and manufacturing supply agreements with Shandong Fiberglass Group Co., Ltd. to manufacture Advantex® glass fiber reinforcements and chopped strand on Shandong Fiberglass’ platform using Owens Corning’s technology and expertise;.

Represented Owens Corning in the technology licensing and manufacturing supply agreements with Taiwan Glass Ind. Corp., based in Taipei, Taiwan produce a mix of products for both thermoplastic and thermoset applications.

Represented TEDA BioMedical in exclusive licensing and commercialization arrangements with a US biotechnology company.

* certain transactions listed above were handled before joining Zhong Lun.

Expert in these Jurisdictions

PRC Bar, 2005

New York State Bar, 2011

Experience

Partner, Arnold & Porter Kaye Scholer LLP

Chief Representative, Shanghai Representative Office

Languages Spoken

Chinese

English